The global Pathogen Reduction Systems for Blood market is experiencing steady growth as healthcare systems intensify efforts to enhance blood transfusion safety. These systems are designed to inactivate a wide range of pathogens, including viruses, bacteria, and parasites, thereby significantly reducing the risk of transfusion-transmitted infections.